| Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. | |
| | |
MedLine Citation:
|
PMID: 20106513 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine. METHODS: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models. RESULTS: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P=0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P=0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P=0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P<0.0001). CONCLUSION: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination. |
| | |
Authors:
|
L Stewart Massad; Charlesnika T Evans; Tracey E Wilson; Johanna L Goderre; Nancy A Hessol; Donna Henry; Christine Colie; Howard D Strickler; Alexandra M Levine; D Heather Watts; Kathleen M Weber |
Related Documents
:
|
10600293 - Synthesis of ifn-gamma by cd8(+) t cells is preserved in hiv-infected women with hpv-re... 9207803 - Human papillomavirus infection in postmenopausal women with and without hormone therapy. 18090693 - Regressive and intensive methods of electroconvulsive therapy: a brief historical note. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2010-01-27 |
Journal Detail:
|
Title: Gynecologic oncology Volume: 117 ISSN: 1095-6859 ISO Abbreviation: Gynecol. Oncol. Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-03-19 Completed Date: 2010-03-30 Revised Date: 2011-07-28 |
Medline Journal Info:
|
Nlm Unique ID: 0365304 Medline TA: Gynecol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 70-6 Citation Subset: IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA. massadl@wudosis.wustl.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cohort Studies Female HIV Infections / complications*, psychology, virology Health Knowledge, Attitudes, Practice* Humans Middle Aged Papillomavirus Infections / complications*, psychology, virology Papillomavirus Vaccines / administration & dosage Patient Education as Topic Uterine Cervical Neoplasms / prevention & control*, psychology, virology* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 CA085178-12/CA/NCI NIH HHS; R01 CA85178-01/CA/NCI NIH HHS; U01-AI-31834/AI/NIAID NIH HHS; U01-AI-34989/AI/NIAID NIH HHS; U01-AI-34993/AI/NIAID NIH HHS; U01-AI-34994/AI/NIAID NIH HHS; U01-AI-35004/AI/NIAID NIH HHS; U01-AI-42590/AI/NIAID NIH HHS; U01-HD-32632/HD/NICHD NIH HHS; UL1 RR024131/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Papillomavirus Vaccines |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quality of care in advanced ovarian cancer: The importance of provider specialty.
Next Document: Determination of heart rate and heart rate variability in the equine fetus by fetomaternal electroca...